Janus Henderson Group PLC raised its stake in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 24.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 133,302 shares of the business services provider's stock after buying an additional 26,432 shares during the period. Janus Henderson Group PLC owned about 0.41% of Cross Country Healthcare worth $2,421,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of CCRN. Quadrant Capital Group LLC purchased a new position in Cross Country Healthcare during the fourth quarter valued at approximately $25,000. Plato Investment Management Ltd purchased a new position in Cross Country Healthcare in the fourth quarter worth about $46,000. Mint Tower Capital Management B.V. purchased a new position in shares of Cross Country Healthcare in the 4th quarter worth approximately $182,000. Guggenheim Capital LLC purchased a new position in Cross Country Healthcare during the fourth quarter worth $201,000. Finally, Envestnet Asset Management Inc. bought a new position in Cross Country Healthcare during the 4th quarter valued at about $217,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Cross Country Healthcare Stock Performance
Shares of CCRN opened at $13.79 on Wednesday. Cross Country Healthcare, Inc. has a 1 year low of $9.58 and a 1 year high of $18.50. The stock has a market capitalization of $452.08 million, a PE ratio of -275.74, a P/E/G ratio of 3.32 and a beta of 0.38. The company's 50-day simple moving average is $14.32 and its 200-day simple moving average is $15.53.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a positive return on equity of 5.38% and a negative net margin of 0.12%. During the same period in the previous year, the firm earned $0.19 EPS. The business's revenue was down 22.6% compared to the same quarter last year. On average, sell-side analysts predict that Cross Country Healthcare, Inc. will post 0.53 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the stock. JMP Securities reissued a "market perform" rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. UBS Group dropped their price target on Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. StockNews.com began coverage on Cross Country Healthcare in a research note on Thursday, May 15th. They issued a "hold" rating for the company. Finally, Barrington Research reiterated a "market perform" rating and issued a $18.61 price objective on shares of Cross Country Healthcare in a research note on Friday, March 14th. Seven research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $17.93.
Read Our Latest Stock Analysis on CCRN
Cross Country Healthcare Profile
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
